Form 4 Tracker
CORCEPT THERAPEUTICS INC
CORT

84 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 31, 2025Mar 31 8:20 PMLyon Joseph Douglas
Proposed Sale
200,000$100.47$20.1M—

View →

Mar 10, 2025Mar 10 3:02 PMSwisher Daniel N JR
Proposed Sale
2,200$53.60$117.9K—

View →

Mar 4, 2025Mar 4 6:59 PMGuyer William
Proposed Sale
20,000$59.07$1.2M—

View →

Mar 3, 2025Mar 3 6:47 PMBELANOFF JOSEPH K
Proposed Sale
40,000$60.58$2.4M—

View →

Mar 3, 2025Mar 3 5:37 PMLyon Joseph Douglas
Proposed Sale
5,000$60.58$302.9K—

View →

Mar 3, 2025Mar 3 5:18 PMMaduck Sean
Proposed Sale
20,000$60.58$1.2M—

View →

Feb 10, 2025Feb 10 4:36 PMSwisher Daniel N JR
Proposed Sale
2,200$68.08$149.8K—

View →

Feb 3, 2025Feb 3 6:33 PMMaduck Sean
Proposed Sale
20,000$66.92$1.3M—

View →

Feb 3, 2025Feb 3 6:17 PMLyon Joseph Douglas
Proposed Sale
5,000$66.92$334.6K—

View →

Jan 10, 2025Jan 10 3:49 PMSwisher Daniel N JR
Proposed Sale
2,200$50.54$111.2K—

View →

Jan 2, 2025Jan 2 5:03 PMMaduck Sean
Proposed Sale
20,000$50.39$1.0M—

View →

Jan 2, 2025Jan 2 4:58 PMRobb Gary Charles
Proposed Sale
11,000$50.45$555.0K—

View →

Jan 2, 2025Jan 2 4:52 PMLyon Joseph Douglas
Proposed Sale
5,000$50.34$251.7K—

View →

Dec 10, 2024Dec 10 3:00 PMSwisher Daniel N JR
Proposed Sale
2,200$59.46$130.8K—

View →

Nov 22, 2024Nov 22 7:36 PMLyon Joseph Douglas
Proposed Sale
1,411$56.72$80.0K—

View →

Nov 22, 2024Nov 22 4:41 PMRobb Gary Charles
Proposed Sale
2,609$56.20$146.6K—

View →

Nov 11, 2024Nov 12 1:21 PMSwisher Daniel N JR
Proposed Sale
2,200$59.88$131.7K—

View →

Nov 1, 2024Nov 1 4:55 PMGuyer William
Proposed Sale
10,000$48.97$489.7K—

View →

Oct 1, 2024Oct 1 4:55 PMRobb Gary Charles
Proposed Sale
11,000$46.28$509.1K—

View →

Oct 1, 2024Oct 1 4:44 PMGuyer William
Proposed Sale
10,000$46.28$462.8K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 1, 2026Jul 6 8:44 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
25,000$8.27116,986(D)

View →

Jun 15, 2026Jun 17 8:30 PMAtabak MokariChief Financial Officer
Option Exercise
40,000$19.2620,000(D)

View →

Jun 2, 2026Jun 4 8:49 PMWilliam GuyerChief Development Officer
Option Exercise
20,000$21.65150,000(D)

View →

Jun 1, 2026Jun 3 11:20 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
25,000$8.27141,986(D)

View →

Jun 1, 2026Jun 3 11:20 PMAtabak MokariChief Financial Officer
Option Exercise
40,000$19.2660,000(D)

View →

May 27, 2026May 29 10:03 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
75,000$8.27166,986(D)

View →

May 21, 2026May 26 9:40 PMBAKER G LEONARD JRDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:39 PMGregg H AltonDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:36 PMJames N WilsonDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:35 PMDaniel N Swisher JRDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:33 PMJoshua M. MurrayDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:31 PMDavid L MahoneyDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:28 PMKimberly ParkDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 5, 2026May 7 8:30 PMWilliam GuyerChief Development Officer
Option Exercise
20,000$21.65170,000(D)

View →

Apr 7, 2026Apr 8 11:34 PMWilliam GuyerChief Development Officer
Option Exercise
20,000$21.65190,000(D)

View →

Mar 20, 2026Mar 24 8:54 PMWilliam GuyerChief Development Officer
Option Exercise
11,767$21.65210,000(D)

View →

Mar 13, 2026Mar 17 11:52 PMDavid L MahoneyDirector
Option Exercise
30,000$5.860(D)

View →

Mar 4, 2026Mar 6 9:30 PMWilliam GuyerChief Development Officer
Option Exercise
8,233$21.65221,767(D)

View →

Feb 27, 2026Mar 3 11:19 PMJoseph Douglas LyonChief Accounting & Technology Officer
Grant/Award
140,000$35.70140,000(D)

View →

Feb 27, 2026Mar 3 11:17 PMBELANOFF JOSEPH KDirector, Chief Executive Officer
Grant/Award
460,000$35.70460,000(D)

View →